Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan-Reference-Cited by-同舟云学术

Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan

Published:2019-01-29 Issue:4 Volume:109 Page:491-498
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Kawashima Nozomu^ORCID,Iida Minako,Suzuki Ritsuro,Fukuda Takahiro,Atsuta Yoshiko,Hashii Yoshiko,Inoue Masami,Kobayashi Masao,Yabe Hiromasa,Okada Keiko,Adachi Souichi,Yuza Yuki,Kawa Keisei,Kato Koji

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-019-02601-5/fulltext.html

Reference27 articles.

1. Kato K, Sakaguchi H, Muramatsu H, Sekiya Y, Kawashima N, Narita A, et al. Danaparoid reduces transplant-related mortality in stem cell transplantation for children. Pediatr Transplant. 2018;22:e13099.

2. Dhir S, Slatter M, Skinner R. Recent advances in the management of graft-versus-host disease. Arch Dis Child. 2014;99:1150–7.

3. Baird K, Cooke K, Schultz KR. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin N Am. 2010;57:297–322.

4. Okamoto S, Teshima T, Kosugi-Kanaya M, Kahata K, Kawashima N, Kato J, et al. Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease. Int J Hematol. 2018;108:298–305.

5. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47:85–118.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body Surface Area-Based Dosing of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Prospective Population Pharmacokinetic Study;Pharmaceutics;2023-12-07

2. Treatment of steroid-refractory graft versus host disease in children;Frontiers in Transplantation;2023-09-15

3. Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan;Frontiers in Pediatrics;2022-02-18

4. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection;International Journal of Hematology;2020-09-01

5. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2020-05-07